A new study harnesses the power of mindfulness to help overanxious people calm themselves — and the benefit may equal the use of an antidepressant, according to researchers at Georgetown University Medical Center in Washington, D.C. Olga Cannistraro said practicing mindfulness certainly helped her. “There was something excessive about the way I responded to my environment,” she explained. Cannistraro, now 52, decided to join a study on mindfulness-based stress reduction (MBSR) for anxiety disorders 10 years ago. The study was led by Dr. Elizabeth Hoge, who directs the Anxiety Disorders Research Program at Georgetown. MBSR “gave me the tools to spy on myself,” Cannistraro explained in a center news release. “Once you have awareness of an anxious reaction, then you can make a choice for how to deal with it. It’s not like a magic cure, but it was a lifelong kind of training. Instead of my anxiety progressing, it went in the other direction and I’m very grateful for that.” The latest study by Hoge’s team seems to confirm those earlier, positive results. Published Nov. 9 in JAMA Psychiatry, the study recruited 276 people with anxiety disorder who were seeking treatment at hospitals in Boston, New York City and Washington, D.C. All were offered either the SSRI antidepressant escitalopram (brand name Lexapro, commonly used to treat anxiety) or eight weeks of MBSR. The mindfulness…  read on >  read on >

Much like intense exercise, vigorous sex can trigger an asthma attack in folks with the chronic lung disease, according to new research. “There is a lack of current literature available on the prevalence of sexual intercourse presenting as exercise-induced asthma,” said study author Dr. Ariel Leung, chief internal medicine resident at Saint Agnes Medical Center in Fresno, Calif. This could be because sex isn’t always the easiest topic to broach with your doctor. “When sexual intercourse-induced asthma is properly identified and treated, allergists are placed in a position where they can improve their patients’ quality of life and even their marriages,” Leung said. When it comes to the risk of having an asthma attack, vigorous sex is akin to walking up two flights of stairs, she noted. The same measures that keep asthma at bay during exercise can also help stave off a sex-induced asthma attack. “We recommend that patients take their short-acting beta agonist inhaler 30 minutes prior to sexual intercourse to prevent an asthma attack,” Leung said. “Some patients might think it takes away from the romance, but nothing is more romantic than taking care of yourself and not having your partner observe an asthma attack.” The wheezing, coughing, shortness of breath and chest tightness that are hallmarks of an asthma attack are caused by inflammation that narrows airways. It can’t be cured…  read on >  read on >

In a finding that challenges the notion that immigrants are freeloaders in the American health care system, a new study shows they are paying a lot more through health care premiums and related taxes than they actually use in care. In fact, the amount that immigrants pay in makes up for some of the amount of health care that non-immigrants use in excess of what they pay. “Some politicians and pundits tell Americans that immigrants are a burden to society, and particularly to our health care system,” senior study author Dr. Steffie Woolhandler, a distinguished professor at City University of New York’s (CUNY) Hunter College and lecturer at Harvard Medical School, said in a CUNY news release. “But the opposite is true. Immigrants subsidize the care of other Americans, to the tune of tens of billions of dollars each year,” she explained. The study found that immigrants paid about $58.3 billion more in health insurance premiums and taxes than insurers and federal, state and local governments paid for their care in 2017. About 89% of immigrants’ total surplus contributions were made by undocumented immigrants. Conversely, Americans born in the United States received $67.2 billion more in care than they actually paid, according to the study authors. To arrive at that unexpected finding, researchers analyzed detailed data from the Census Bureau’s Current Population Survey, the American…  read on >  read on >

Equipping offices with “healthier” furnishings could reduce human exposure to risky PFAS chemicals, new research suggests. To look at indoor PFAS levels, a team led by Harvard T.H. Chan School of Public Health, in Boston, analyzed building dust in classrooms and common campus spaces. “Our findings provide desperately needed scientific evidence for the success of healthier materials — which don’t have to be more expensive or perform less well — as a real-world solution to reduce indoor exposure to forever chemicals as a whole,” said Anna Young, lead author of the study. She’s a research associate in the department of environmental health and associate director of Harvard’s Healthy Buildings program. PFAS — or per- and polyfluoroalkyl substances — are called “forever chemicals” because they persist in the environment. Used for stain and water resistance, at least 12,000 types of PFAS are found in products such as furniture, carpet, textiles, food packaging, nonstick cookware, cosmetics and firefighting foam. Linked to thyroid disease, stunted development, weakened immune systems, high cholesterol, testicular cancer, obesity and diabetes, these chemicals have been detected in the blood of more than 98% of Americans. For this study, the researchers wanted to expand on an earlier investigation that looked at 15 types of PFAS in buildings. It’s difficult because most of the thousands of PFAS chemicals are unknown or can’t be measured with…  read on >  read on >

Evaluating a person’s psychological stress can be a good way to gauge their risk of heart and blood vessel disease, new research suggests. And a brief questionnaire could help with the assessment, the study findings showed. “Our study is part of the accumulating evidence that psychological distress is a really important factor in a cardiovascular diagnosis, such as the other health behaviors and risk factors, like physical activity and cholesterol levels, that clinicians monitor,” said co-author Emily Gathright. She is an assistant professor of psychiatry and human behavior at Brown University’s Warren Alpert Medical School, in Providence, R.I. For the study, the team looked at research published within the past five years that included adults without a psychiatric diagnosis who were screened for depression, anxiety, post-traumatic stress disorder, stress or general mental health symptoms, and followed for more than six months. About 58% were women. In all, Gathright and her colleagues analyzed findings from 28 studies that included more than 658,000 patients. Those reporting high levels of psychological distress had a 28% higher risk of heart disease, the investigators found. According to study co-author Carly Goldstein, an assistant professor of psychiatry and human behavior, a brief mental health questionnaire can give clinicians a better idea not only of a patient’s mental health risks, but also their associated risk for heart disease. Based on the results…  read on >  read on >

Folks taking dietary supplements intended to help their heart health are just wasting their money, a new clinical trial suggests. Six supplements widely promoted as heart-healthy — fish oil, cinnamon, garlic, turmeric, plant sterols and red yeast rice — didn’t do a thing to lower “bad” low-density lipoprotein (LDL) cholesterol or improve heart health, researchers found. “Compared to placebo, none of the supplements had a significant decrease in LDL cholesterol,” said lead researcher Dr. Luke Laffin, co-director of the Cleveland Clinic’s Center for Blood Pressure Disorders. In fact, two of the supplements made matters worse, Laffin said during a presentation on the findings Sunday at the American Heart Association’s annual meeting, in Chicago. The study findings were published Nov. 6 in the Journal of the American College of Cardiology. The garlic supplement actually increased LDL cholesterol by nearly 8%, while plant sterols decreased “good” high-density lipoprotein (HDL) cholesterol levels by more than 7%, the results showed. The clinical trial also demonstrated that statins are incredibly effective in lowering cholesterol. A low dose of cholesterol-lowering rosuvastatin (Crestor) prompted, on average, a nearly 38% decrease in bad LDL cholesterol, Laffin said. “Every participant randomized to rosuvastatin had at least an 18.2% reduction in LDL cholesterol, with half receiving over 40% reduction in LDL cholesterol,” Laffin said. “Whereas with all the supplements and placebo, you might as well…  read on >  read on >

As the daylight hours shrink, people’s moods can wind up in the tank. Rest assured, you’re not alone. It’s the SAD season for those affected by seasonal affective disorder. That’s the depression, fatigue and withdrawal that shorter days and longer nights often bring. “The seasonal mood change can come in different shapes and forms,” said Dr. Dorothy Sit, associate professor of psychiatry and behavioral sciences at Northwestern University Feinberg School of Medicine, in Chicago. “It can be a clinical diagnosis of depression, which we call SAD, but some people experience a milder form,” Sit said. “The clinical diagnosis means it is quite intense; it affects people all day for many weeks and can impact their functioning. In milder cases, people can feel a bit blah, but can push through. Still, functioning will feel a bit harder.” Besides feeling sluggish, people may be hungrier, crave carbohydrates, eat more and gain weight. They may also feel less motivated and find less enjoyment in activities. “This is a form of depression that cycles naturally; it starts every fall and winter and remits every spring and summer,” Sit said in a Northwestern Medicine news release. A major remedy for SAD is starting the day with bright light therapy. Sit recommends a unit that produces 10,000 LUX of white light to be used in the 30 minutes after waking up.…  read on >  read on >

Deaths caused by alcohol skyrocketed in the United States between 2019 and 2020 as the COVID-19 pandemic took hold, according to a just-published government report. The alcohol-induced death rate jumped 26% during that period, claiming more than 49,000 lives, the U.S. Centers for Disease Control and Prevention reported Friday. That’s about 13 deaths for every 100,000 people. In 2019, the alcohol-induced death rate stood at 10.4 deaths per 100,000, CNN reported. Americans drank more during the COVID pandemic than before, and a health expert said it’s possible this is just the beginning of a disturbing trend. “We know that in large-scale traumatic events to the population – like 9/11 or Hurricane Katrina – people historically start drinking more. The pandemic has been, as we all know, a major stressor to our lives,” said George Koob, director of the U.S. National Institute on Alcohol Abuse and Alcoholism. “What we’ve been picking up with numerous small studies is that about 25% of the population increased their drinking and these individuals were people who were drinking to cope with stress,” he said. “And many people who drink to cope with stress inevitably go on to have an alcohol use disorder.” More than half of the 2020 deaths caused by alcohol were due to alcoholic liver disease, CNN reported. Other causes included mental health and behavioral disorders due to…  read on >  read on >

The U.S. Food and Drug Administration has proposed limiting the amount of nicotine in cigarettes to minimally addictive levels, but there’s been concern that the drop in nicotine could exacerbate anxieties in smokers who might already battle mood issues. However, a new study shows that while cigarettes with nicotine at 5% of the normal dose can help anxious or depressed smokers quit, they do so without adding to mood or anxiety problems that led them to smoke in the first place. “There do not appear to be any concerning, unintended consequences of having to switch to very low nicotine cigarettes,” said lead researcher Jonathan Foulds, a professor of public health sciences and psychiatry at Penn State University School of Medicine. “On the contrary, it appears that the result is that smokers feel less addicted to their cigarettes and more able to quit smoking when offered relatively brief assistance with follow-up appointments plus nicotine replacement therapy,” he said. Smokers with mood and anxiety disorders showed no signs of “over-smoking” the very low-nicotine cigarettes, nor was there any sign that switching to them made their mental health worse, Foulds said. The U.S. Food and Drug Administration has proposed limiting the amount of nicotine in cigarettes to minimally addictive levels. Doing so could not only lessen addiction, but also reduce exposure to toxic substances and increase the odds…  read on >  read on >

A single psychedelic trip with psilocybin — the mind-altering component of magic mushrooms — appears to lift the fog of major depression in some hard-to-treat patients, a new clinical trial reports. A 25-milligram dose of a synthetic psilocybin compound called COMP360 caused a “rapid and durable response” in more than a third of patients suffering from treatment-resistant depression, said Dr. Steve Levine, senior vice president of patient access for the London-based pharmaceutical company COMPASS Pathways. It focuses on psilocybin research and created the COMP360 synthetic compound and funded the clinical trial. The results occurred in a phase 2 trial aimed at finding the most effective dose of COMP360, according to a report published Nov. 3 in the New England Journal of Medicine. However, there was one caveat: While side effects were minimal, four patients (out of 79) who took the highest dose either reported having suicidal thoughts or intentionally harming themselves in the weeks that followed. The psilocybin compound will now proceed to a full-fledged clinical trial that promises to be the largest ever conducted for a psychedelic compound, Levine said. The trial testing its effectiveness is expected to include more than 900 people in 14 countries, including the United States, Levine said. It’s expected to conclude in mid-2025. These early findings show that psilocybin could well provide an alternative to standard treatments for major…  read on >  read on >